An FDA Center for Devices and Radiological Health webcast on Tuesday aimed to address medical-device firms' and other industry members' concerns about a future revamped 510(k) process. "By increasing the predictability and reliability of the review process, we can ensure patient safety and foster innovation," said Jeffrey Shuren, director of the agency's device center.

Related Summaries